January 8, 2026 January 8, 2026Categories News StoriesWATCH: Dr. Joe Sparano discusses a new AI tool for breast cancer recurrence screening
January 4, 2026 January 4, 2026Categories News StoriesJAMA publishes ALCHEMIST EA5142 results: Nivolumab does not further reduce risk of recurrence in non-small cell lung cancer patients who completed standard post-surgery treatment
December 22, 2025 December 22, 2025Categories Announcements News StoriesThe December 2025 News from ECOG-ACRIN blog is now available
December 22, 2025 December 22, 2025Categories News StoriesWATCH: Dr. Joe Sparano talks with LinkedIn News about using AI for predicting breast cancer recurrence
December 3, 2025 December 3, 2025Categories News StoriesNIH implements “zero-embargo” revisions to its public access policy for published scientific research
November 21, 2025 November 21, 2025Categories Announcements News StoriesThe November 2025 News from ECOG-ACRIN blog is now available
November 4, 2025 November 4, 2025Categories Announcements News StoriesThe Fall 2025 advocacy blog, Considering Clinical Trials, is now available
November 3, 2025 November 3, 2025Categories News StoriesSTAMP (EA6174), the largest trial of adjuvant pembrolizumab in Merkel cell carcinoma, reports key benefit
October 30, 2025 October 30, 2025Categories News StoriesWATCH: Dr. Janice Mehnert discusses STAMP (EA6174) trial results; adjuvant pembrolizumab in resected Merkel cell carcinoma shows improved distant metastasis-free survival
